Weight-loss drugs like Ozempic and Wegovy are used by more than 15 million adults in the U.S., or 4.5% of the population.

Drug containment and delivery solutions provider SCHOTT Pharma has announced an investment of more than €100m ($114m) to ...

Mounjaro is generally considered safe for use under medical supervision, especially for individuals who are overweight or ...

Mounjaro is the brand name for tirzepatide, a prescription medication developed by Eli Lilly that is primarily used to treat ...

Over the past decade, the global pharmaceutical industry has witnessed a transformation in the treatment landscape for ...

In this edition of Open Interest, we look at how the focus on GLP-1 could reduce household dietary intake and grocery bills.

Eli Lilly and Company thrives on its groundbreaking weight-loss drug tirzepatide. Learn why we could see a $50B market and ...

Orforglipron (pronounced or-for-GLIP-ron) might be a mouthful to say, but Indianapolis-based Eli Lilly and Co. sees this ...

Simple Promise's Revolutionary GLP-1 Electrolyte Formula Blends Hydration with Metabolic Support for Real, Sustainable Weight ...

Reviewing the bioequivalence study of the antidiabetic drug Semaglutide of MSN Laboratories, the Subject Expert Committee ...

Dietary fiber is essential for digestive, cardiovascular, and metabolic health, but most people fall short of daily ...

Improves fibrosis and steatohepatitis Metabolic dysfunction-associated steatotic liver disease (MASLD) encompasses a broad clinical spectrum, ranging from simple steatosis to metabolic ...